Aurobindo Pharma Limited has informed the Exchange about dispatch of letter providing weblink and path for Annual Report 2024-25
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges that it has sent a letter to shareholders (who have not registered their email IDs) providing a web-link and navigation path to access the Integrated Annual Report 2024-25 and the 38th AGM Notice, as required under SEBI Listing Regulations. The 38th Annual General Meeting is scheduled for Wednesday, September 10, 2025, at 3:30 p.m. IST via Video Conferencing. E-voting will be open from Sunday, September 7, 2025 (9:00 a.m.) to Tuesday, September 9, 2025 (5:00 p.m.), with a cut-off date of September 3, 2025. Shareholders have also been reminded to update their PAN, KYC, and nomination details to ensure timely receipt of dividends, and a senior citizens investor cell has been set up by the RTA for grievance support.
This is a routine regulatory disclosure with no direct impact on stock price or shareholder value. It signals that the 38th AGM is approaching, and shareholders should review the annual report and exercise their e-voting rights between September 7–9, 2025. Failure to update KYC details could delay dividend payments.